References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Ariasetal(2004)Galantaminepreventsapoptosisinducedbyβ-amyloidandthapsigargin:involvementofnicotinicacetycholinereceptors.Neuropharmacology46103PMID:14654102
Capsonietal(2002)Nervegrowthfactorandgalantamineameliorateearlysignsofneurodegenerationinanti-nervegrowthfactormice.Proc.Natl.Acad.Sci.U.S.A.9912432PMID:12205295
Harvey(1995)Thepharmacologyofgalanthamineanditsanalogues.Pharmacol.Ther.68113PMID:8604434
Samochockietal(2003)Galantamineisanallostericallypotentiatingligandofneuronalnicotinicbutnotofmuscarinicacetylcholinereceptors.J.Pharmacol.Exp.Ther.3051024PMID:12649296
Sweeneyetal(1989)Galanthamine,anacetylcholinesteraseinhibitor:atimecourseoftheeffectsonperformanceandneuRochemicalparametersinmice.Pharmacol.Biochem.Behav.34129PMID:2626444
Keywords:Galanthaminehydrobromide,supplier,Galanthamine,Galantamine,Cholinesterase,inhibitors,inhibits,AChE,Acetylcholinesterase,Esterases,Muscarinic,Receptors,Acetylcholine,Nicotinic,nAChR,Cholinesterases,Nicotinic,Receptors,(Non-selective),Cholinesterases,TocrisBioscience